Pupil Response Biomarkers Distinguish Amyloid Precursor Protein Mutation Carriers from Non-Carriers

被引:2
|
作者
Frost, Shaun M. [1 ,2 ]
Kanagasingam, Yogesan [1 ,2 ]
Sohrabi, Hamid R. [3 ,4 ]
Taddei, Kevin [4 ]
Bateman, Randall [5 ]
Morris, John [5 ]
Benzinger, Tammie [5 ]
Goate, Alison [5 ]
Masters, Colin L. [6 ]
Martins, Ralph N. [4 ]
机构
[1] CSIRO, Perth, WA, Australia
[2] Australian E Hlth Res Ctr, Perth, WA, Australia
[3] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia
[4] Edith Cowan Univ, McCusker Alzheimers Res Fdn, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Perth, WA, Australia
[5] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[6] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia
关键词
Alzheimer's; autosomal; amyloid; eye; pupil; ONSET ALZHEIMERS-DISEASE; PITTSBURGH COMPOUND-B; CEREBROSPINAL-FLUID; LIGHT REFLEXES; TROPICAMIDE; SIZE; DILATATION; DILATION; DEMENTIA; BRAIN;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Context: Alzheimer's disease (AD) is usually only diagnosed many years after pathology begins. Earlier detection would allow emerging interventions to have a greater chance to preserve healthy brain function. A rare form of Alzheimer's disease, caused by autosomal-dominant mutations, affects carriers with 100% certainty and at a younger age specific to their mutation. Studying families with these mutations allows a unique investigation of the temporal sequence of biomarker changes in Alzheimer's disease. Objective: To determine whether the pupil flash response (PFR), previously reported to be altered in sporadic Alzheimer's disease, is different in pre-symptomatic mutation carriers. Design: Researchers blinded to participant mutation status collected pupil response data from cognitively normal participants in the Dominantly Inherited Alzheimer's Network (DIAN) Study during 2010-2011. Setting: The pupil response was examined at the McCusker Alzheimer's Research Foundation in Perth, Western Australia. Participants: Participants were from a single family harboring an Amyloid-Beta Precursor Protein genetic mutation (APPGlu693Gln). Six carriers and six non-carriers were available for pupil testing (age 43.0 +/- 8.3 years old, 2 males and 10 females, 4 with hypertension). Main Outcome Measure: Pupil response parameter comparison between mutation carriers and non-carriers. Results: 75% recovery time was longer in mutation carriers (p<0.0003, ROC AUC 1.000, Sensitivity 100%, Specificity 100%) and percentage recovery 3.5 seconds after stimulus was less in mutation carriers (p<0.006, ROC AUC 1.000, Sensitivity 100%, Specificity 100%). Conclusions: PFR changes occur pre-symptomatically in autosomal dominant AD mutation carriers, supporting further investigation of PFR for early detection of AD.
引用
收藏
页码:790 / 796
页数:7
相关论文
共 16 条
  • [1] Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
    Remnestal, Julia
    Oijerstedt, Linn
    Ullgren, Abbe
    Olofsson, Jennie
    Bergstrom, Sofia
    Kultima, Kim
    Ingelsson, Martin
    Kilander, Lena
    Uhlen, Mathias
    Manberg, Anna
    Graff, Caroline
    Nilsson, Peter
    TRANSLATIONAL NEURODEGENERATION, 2020, 9 (01)
  • [2] Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
    Julia Remnestål
    Linn Öijerstedt
    Abbe Ullgren
    Jennie Olofsson
    Sofia Bergström
    Kim Kultima
    Martin Ingelsson
    Lena Kilander
    Mathias Uhlén
    Anna Månberg
    Caroline Graff
    Peter Nilsson
    Translational Neurodegeneration, 9
  • [3] Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease
    Almkvist, Ove
    Larsson, Maria
    Graff, Caroline
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (02) : 587 - 598
  • [4] Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers
    Kowalewski, Joel
    Murphy, Claire
    BRAIN RESEARCH, 2012, 1442 : 55 - 65
  • [5] Cortical volumes and atrophy rates in FTD-3 CHMP2B mutation carriers and related non-carriers
    Eskildsen, Simon F.
    Ostergaard, Lasse R.
    Rodell, Anders B.
    Ostergaard, Leif
    Nielsen, Jorgen E.
    Isaacs, Adrian M.
    Johannsen, Peter
    NEUROIMAGE, 2009, 45 (03) : 713 - 721
  • [6] Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer's Disease Trajectory?
    Femminella, Grazia Daniela
    Taylor-Davies, Genevieve
    Scott, James
    Edison, Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 (03) : 981 - 993
  • [7] Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees
    Klunk, William E.
    Price, Julie C.
    Mathis, Chester A.
    Tsopelas, Nicholas D.
    Lopresti, Brian J.
    Ziolko, Scott K.
    Bi, Wenzhu
    Hoge, Jessica A.
    Cohen, Ann D.
    Ikonomovic, Milos D.
    Saxton, Judith A.
    Snitz, Beth E.
    Pollen, Daniel A.
    Moonis, Majaz
    Lippa, Carol F.
    Swearer, Joan M.
    Johnson, Keith A.
    Rentz, Dorene M.
    Fischman, Alan J.
    Aizenstein, Howard J.
    DeKosky, Steven T.
    JOURNAL OF NEUROSCIENCE, 2007, 27 (23) : 6174 - 6184
  • [8] Practice effects in cognitive assessments three years later in non-carriers but not in symptom-free mutation carriers of autosomal-dominant Alzheimer's disease: Exemplifying procedural learning and memory?
    Almkvist, Ove
    Graff, Caroline
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [9] Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial
    Vila-Castelar, Clara
    Tariot, Pierre N.
    Sink, Kaycee M.
    Clayton, David
    Langbaum, Jessica B.
    Thomas, Ronald G.
    Chen, Yinghua
    Su, Yi
    Chen, Kewei
    Hu, Nan
    Giraldo-Chica, Margarita
    Tobon, Carlos
    Acosta-Baena, Natalia
    Luna, Ernesto
    Londono, Marisol
    Ospina, Paula
    Tirado, Victoria
    Munoz, Claudia
    Henao, Eliana
    Bocanegra, Yamile
    Alvarez, Sergio
    Rios-Romenets, Silvia
    Ghisays, Valentina
    Goradia, Dhruman
    Lee, Wendy
    Luo, Ji
    Malek-Ahmadi, Michael H.
    Protas, Hillary D.
    Lopera, Francisco
    Reiman, Eric M.
    Quiroz, Yakeel T.
    ALZHEIMERS & DEMENTIA, 2022, 18 (11) : 2272 - 2282
  • [10] The detection of GRN mutation carriers by progranulin blood protein levels from finger-stick collection
    Huber, Hanna
    Cantoni, Valentina
    Altomare, Daniele
    Grotschel, Lana
    Montoliu-Gaya, Laia
    Meda, Francisco
    Kvartsberg, Hlin
    Libri, Ilenia
    Cotelli, Maria Sofia
    Zetterberg, Henrik
    Blennow, Kaj
    Borroni, Barbara
    Ashton, Nicholas J.
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)